LHP588 is an oral, brain-penetrant lysine-gingipain (Kgp) inhibitor designed to block the key virulence factor of P. gingivalis
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
Roche also shared the design of its upcoming Phase III TRONTIER 1 and 2 trials investigating trontinemab in people with early symptomatic Alzheimer’s disease
Neuberg group commits to invest over Rs. 100 crores to start diagnostics facilities across Jharkhand in the next 2-3 years
The new Zigly center features and offers comprehensive veterinary services
For over 13 years, Star Imaging has pioneered the introduction of next-generation radiology technologies in Pune
Genomics is transforming the future of modern medicine and treatment modalities across specialties
More than 40 types of Amyloid proteins are discovered till date
Subscribe To Our Newsletter & Stay Updated